Income Taxes (Tables)

12 Months Ended

Dec. 31, 2018

Income Tax Disclosure [Abstract]

Schedule of Income Tax Expense (Benefit)

The income tax benefit attributable to loss before income taxes for the years ended December 31, 2018 and 2017 is as follows:

	Years Ended December 31,
	2018			2017
Current:
State	$	(93,000	)	$	(1,789,000	)
Total current tax benefit		(93,000	)		(1,789,000	)
Total deferred tax benefit		-			-
Income tax benefit	$	(93,000	)	$	(1,789,000	)

Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the income tax benefit computed at the statutory tax rate to the Company’s effective tax rate for the years ended December 31, 2018 and 2017 is as follows:

	Years Ended December 31,
	2018			2017
U.S. federal statutory rate		21.00	%		35.00	%
State taxes		5.25	%		(21.84	)%
Sale of NJ NOLS and credits		(2.78	)%		(68.91	)%
Change in federal statutory rate		-	%		(441.07	)%
Stock based compensation		(1.96	)%		(5.48	)%
Other permanent difference due to sale of NJ NOLs and credits		-	%		(24.12	)%
Federal research and development credits		2.28	%		2.24	%
Other		(0.11	)%		(12.46	)%
Valuation allowance		(26.46	)%		467.73	%
Effective tax rate		(2.78	)%		(68.91	)%

Schedule of Deferred Tax Assets

Significant components of the Company’s deferred tax assets as of December 31, 2018 and 2017 are as follows:

	December 31,
	2018			2017
Deferred tax assets:
Net operating loss carry forwards	$	18,671,000		$	17,907,000
Research and development credits		1,399,000			1,322,000
Nonqualified stock option compensation expense		497,000			453,000
Other temporary book - tax differences		58,000			125,000
Total deferred tax assets		20,625,000			19,807,000
Deferred tax liabilities:
Fixed and intangible asset basis difference		(21,000	)		-
Total deferred tax liabilities		(21,000	)		-
Deferred tax assets (liabilities), net		20,604,000			19,807,000
Valuation allowance for deferred tax assets		(20,604,000	)		(19,807,000	)
Deferred tax assets (liabilities), net after valuation allowance	$	-		$	-